Growth Hormone Axis
Used as a research probe of pituitary GH secretory reserve; the GHRH stimulation test has historically been employed to assess somatotroph function.
GHRH stimulation literature
Prompts your body to make its own growth hormone naturally
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Sermorelin is a growth-hormone-releasing peptide researched for prompting the body to make its own growth hormone naturally — supporting recovery, sleep, and healthy aging while keeping the body's normal hormonal rhythm intact.
Growth hormone-releasing hormone (GHRH) analog; N-terminal 29-amino-acid fragment of human GHRH
The pathways Sermorelin acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Sermorelin binds growth hormone-releasing hormone receptors on anterior-pituitary somatotrophs, stimulating the synthesis and pulsatile release of endogenous growth hormone rather than supplying it exogenously.
Increased growth hormone drives hepatic production of insulin-like growth factor 1 (IGF-1), the principal mediator of GH's anabolic and metabolic effects on muscle, bone, connective tissue, and lipid metabolism.
Because stimulation acts upstream at the pituitary, GH output remains subject to somatostatin and IGF-1 negative feedback, helping maintain a natural secretory rhythm instead of a fixed exogenous level.
Unlike recombinant HGH, which delivers growth hormone directly, Sermorelin prompts the pituitary to release its own GH — preserving the hypothalamic–pituitary axis and its regulatory checkpoints.
The main areas Sermorelin is being studied for — and the study-reported figures behind them.
Used as a research probe of pituitary GH secretory reserve; the GHRH stimulation test has historically been employed to assess somatotroph function.
GHRH stimulation literatureGH secretagogues are studied for their influence on lean body mass, fat mass, and metabolic rate in models of age- or disease-related GH decline.
Body-composition researchEndogenous GH release is tightly coupled to slow-wave sleep, so GHRH analogs are studied to explore the link between the somatotropic axis and sleep architecture.
Sleep-axis researchAge-related decline in GH and IGF-1 — termed somatopause — is modeled with GHRH analogs to investigate restoration of more youthful secretory patterns.
Aging-axis researchAn interactive 3D model rendered from the compound record — rotate and explore its structure.
C149H246N44O42S
How Sermorelin clears from circulation, modeled from its documented ~~10–20 minutes (plasma) half-life. The curve draws as you scroll.
Every batch of Sermorelin is sent to an accredited independent laboratory before it ships. Here is what we screen for.
| Compound Class | Growth hormone-releasing hormone (GHRH) analog |
| Research Name | Sermorelin (GHRH 1–29) |
| Sequence | N-terminal 29-amino-acid fragment of human GHRH |
| Target | GHRH receptor (pituitary somatotrophs) |
| Form | Lyophilized powder |
| Molecular Weight | 3,357.93 g/mol |
| Purity | ≥99% (HPLC verified) |
| Testing | Third-party HPLC, Mass Spec, Endotoxin |
| Half-Life | ~10–20 minutes (plasma) |
| Storage (Lyophilized) | -20°C for long-term stability |
| Storage (Reconstituted) | 2–8°C, use within 14 days |
| Solubility | Bacteriostatic water for reconstitution |
| COA | Included with every order |
| Appearance | White to off-white powder |
| Quantity | 5mg |
| Stability | 24 months from manufacture date when stored properly |
Sermorelin is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH) — the shortest fully active fragment. It stimulates the pituitary to secrete the body's own growth hormone in a natural, pulsatile fashion.
Recombinant HGH supplies growth hormone directly, whereas Sermorelin stimulates endogenous GH release by acting upstream at the pituitary. This preserves the hypothalamic–pituitary feedback loop and a more physiologic secretory rhythm.
Sermorelin has a molecular weight of 3,357.93 g/mol. Every vial is supplied at ≥99% purity, verified by HPLC, with a Certificate of Analysis included.
Keep lyophilized vials at -20°C for long-term stability. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within approximately 14 days.
No. Sermorelin is sold strictly as a research compound for laboratory and in-vitro use only. It is not intended for human or animal consumption, diagnosis, or treatment.
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.